1-2 of 2
Keywords: T1b prostate cancer
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Active Surveillance for Incidental (cT1a/b) Prostate Cancer: Long-Term Outcomes of the Prospective Noninterventional HAROW Study

Available to Purchase
Subject Area:
Further Areas
Jan Herden, Andreas Schwarte, Edith A. Boedefeld, Lothar Weissbach
Journal: Urologia Internationalis
Urol Int (2021) 105 (5-6): 428–435.
https://doi.org/10.1159/000512893
Published Online: 29 January 2021
... T1a prostate cancer T1b prostate cancer Recently, several diagnostic procedures, such as multiparametric magnetic resonance imaging (mpMRI) or prostate health index, have become available to increase the prediction of IPC [ 20, 21 ]. On the other hand, it has so far been difficult...
View article titled, Active Surveillance for Incidental (cT1a/b) Prostate Cancer: Long-Term Outcomes of the Prospective Noninterventional HAROW Study
Open the PDF for Active Surveillance for Incidental (cT1a/b) Prostate Cancer: Long-Term Outcomes of the Prospective Noninterventional HAROW Study in another window
Journal Articles

Treatment of Incidental Prostate Cancer by Active Surveillance: Results of the HAROW Study

Available to Purchase
Subject Area:
Further Areas
Jan Herden, Okyaz Eminaga, Sebastian Wille, Lothar Weissbach
Journal: Urologia Internationalis
Urol Int (2015) 95 (2): 209–215.
https://doi.org/10.1159/000431024
Published Online: 30 May 2015
... model for stage T1a and T1b prostate cancer by assessments of cancer extent. Mod Pathol 2011;24:58-63. The HAROW study was initiated to investigate the provision of ongoing medical care for patients with localized prostate cancer in Germany in a prospective, noninterventional setting...
View article titled, Treatment of Incidental Prostate Cancer by Active Surveillance: Results of the HAROW Study
Open the PDF for Treatment of Incidental Prostate Cancer by Active Surveillance: Results of the HAROW Study in another window